Sponsor:
Matthew Spector
Code:
NCT06831149
Conditions
Squamous Cell Carcinoma
Pharyngocutaneous Fistula
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Removal of pharyngeal mucosa with decreased perfusion will be performed
SPY-PHI
ICG (Indocyanine Green)
Brief summary:
Conditions
Squamous Cell Carcinoma
Pharyngocutaneous Fistula
Study ID
NCT06831149
Start date
Feb 28, 2025
Status verified date
Jan, 2026
Completion date
Feb 28, 2030
Anticipated
Primary completion date
Feb 28, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
225 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: Patients having salvage TL after failure with radiation or chemoradiation
Interventions
Removal of pharyngeal mucosa with decreased perfusion will be performed
SPY-PHI
ICG (Indocyanine Green)
Primary outcome measure
Central contacts
Locations
UPMC
Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contacts
Sponsor
Matthew Spector
Last update posted
Jan 9, 2026
Last verified
Jan, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Matthew Spector on 2026-01-09.